SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Max Medical Services Ltd. - (Amalgamated) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 NSE: | Construction - Real Estate | Small Cap

BSE Share Price
Not Listed

Max Medical Services Ltd. - (Amalgamated)

BSE: 0 NSE:
Key Metrics
Market Cap
₹0 Cr.
P/E Ratio
0.00
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Return on Capital Employed (ROCE)
14.54%
Current Price
₹0
Return on Equity (ROE)
16.28%
Return on Assets (ROA)
9.71%
Operating Profit Margin
42.8%
Net Profit Margin
31.92%
Gross Profit Margin
51.7%
Book Value per Share
₹0
Sales Growth (YoY)
2.91%
Sales Growth (3 Years)
-7.04%
Operating Profit Growth (1 Year)
12.54%
Operating Profit Growth (3 Years)
21.65%
Net Profit Growth (1 Year)
145.39%
52-Week Low / High
₹0 / 0
Net Profit Growth (3 Years)
N/A%
Dividend Yield
0.00%
Promoter Holding
%
Pledged shares (%)
of Promoter's holding (%)
%

DeciZen - make an informed investing decision on Max Medical Services

Based on:

M-Cap below 100cr DeciZen not available

Max Medical Services Ltd. - (Amalgamated) stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
ROCE % 9.5%5%6.5%7.3%6.9%8.7%10.1%14.5%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 26.656.844.848.75542.44344.244
Sales YoY Gr.-113.3%-21.1%8.6%13.1%-22.9%1.3%2.9%-
Adj EPS 1.8-6.1-9.4-3.2-0.301.74.10
YoY Gr.--438.6%NANANANANA145.8%-
BVPS (₹) 5-0.2-9.522.121.821.823.327.50
Adj Net
Profit
2.5-8.6-13.3-10.9-105.814.10
Cash Flow from Ops. 3.13.72.649.646.765.37.536.8-
Debt/CF from Ops. 45.45384.42.42.418.50.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-0.3%-7%2.9%
Adj EPS NANANA145.8%
BVPSNANA8%17.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
Return on
Equity %
31.9-223.7193.6-35.2-1.407.516.30
Op. Profit
Mgn %
39.49.123.725.919.13139.242.8NAN
Net Profit
Mgn %
9.5-15.1-29.6-22.5-1.9013.431.90
Debt to
Equity
19.9-740.5-16.31.61.50.90.80.4-
Working Cap
Days
09901,4041,2499178175935730
Cash Conv.
Cycle
031032042753531042890

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 44.2 -
BVPS (₹) 0 -
Reserves (₹ Cr.) 60 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 46.8

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Max Medical Services - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Sales26.6256.7944.8248.6655.0342.4142.9644.21
Operating Expenses + 16.1751.9834.2036.0444.5129.2826.1325.27
Manufacturing Costs3.193.392.733.963.550.0100
Material Costs11.0446.6129.1528.3638.6127.2624.7724.15
Employee Cost 0.270.390.020.031.291.441.080.59
Other Costs 1.661.592.303.691.060.570.280.53
Operating Profit 10.454.8110.6212.6210.5213.1316.8318.94
Operating Profit Margin (%) 39.3%8.5%23.7%25.9%19.1%31.0%39.2%42.8%
Other Income + 6.417.908.609.099.708.308.489.49
Exceptional Items 00000000
Interest 16.6917.4726.1525.8414.1913.778.645.56
Depreciation 2.904.036.236.987.047.3010.928.76
Profit Before Tax -2.73-8.79-13.16-11.11-1.010.365.7514.11
Tax -5.23-0.590-0.1900.3600
Profit After Tax 2.50-8.20-13.16-10.92-1.0105.7514.11
PAT Margin (%) 9.4%-14.4%-29.4%-22.4%-1.8%0.0%13.4%31.9%
Adjusted EPS (₹)1.8-5.8-9.3-3.2-0.30.01.74.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16

Equity and Liabilities

Shareholders Fund + 7.94-0.27-13.4375.5574.5474.5479.6393.74
Share Capital 14.1414.1414.1434.1434.1434.1434.1434.14
Reserves -6.21-14.41-27.5741.4140.4040.4045.4959.60
Debt +140.26197.34217.80118.98108.8766.8363.6333.48
Long Term Debt140.26197.343.211.73066.8363.6333.48
Short Term Debt00214.59117.25108.87000
Minority Interest00000000
Trade Payables5.2710.817.60911.6011.279.797.76
Others Liabilities 38.8541.5761.6738.4425.140.202.280.22
Total Liabilities 192.32249.45273.64241.97220.15152.84155.33135.20

Fixed Assets

Net Fixed Assets +31.3570.6872.1776.2869.8062.2650.8144.75
Gross Block43.8187.0394.74105.83106.37104.13102.60103.24
Accumulated Depreciation12.4616.3522.5729.5536.5741.8751.7958.49
CWIP 1.390.375.820002.640.47
Investments 13.4813.4813.4813.4825.4825.4825.4825.48
Inventories01.900.0700000.05
Trade Receivables54.7956.5941.4892.6891.147.6926.8317.84
Cash Equivalents 0.511.640.680.600.110.061.780.22
Others Assets 90.80104.80139.9458.9333.6257.3547.7946.39
Total Assets 192.32249.45273.64241.97220.15152.84155.33135.20

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Cash Flow From Operating Activity + 3.093.722.6049.6446.6665.287.5236.75
PBT -2.73-8.79-13.16-11.11-1.010.365.7514.11
Adjustment 20.4424.042.593.384.4819.6310.668.55
Changes in Working Capital -14.61-11.52-13.631.3229.0445.77-17.589.76
Tax Paid 000.6200-0.500.05-1.23
Cash Flow From Investing Activity + -2.37-41.93-13.20-4.13-10.279.823.81-0.38
Capex 0-43.74-13.22-5.27-0.570.22-1.36-2.14
Net Investments -0.010000000
Others -2.361.810.021.14-9.709.605.171.76
Cash Flow From Financing Activity -0.5339.349.64-45.59-36.88-75.15-11.32-36.22
Net Proceeds from Shares + 0001000000
Net Proceeds from Borrowing 11.6457.08000000
Interest Paid -12.17-17.74-7.60-49.19-27.46-33.11-8.12-6.07
Dividend Paid 00000000
Others 0017.24-96.40-9.42-42.04-3.20-30.15
Net Cash Flow 0.191.14-0.96-0.08-0.49-0.050.010.15

Finance Ratio

PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Ratios
ROE (%)35.37N/AN/A-35.16-1.3507.4616.28
ROCE (%)9.47N/AN/A7.326.918.6510.1114.54
Asset Turnover Ratio0.140.260.170.190.240.230.280.3
PAT to CFO Conversion(x)1.24N/AN/AN/AN/AN/A1.312.6
Working Capital Days
Receivable Days751358399503610425147184
Inventory Days06800000
Payable Days1746311510797153155133

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Max Medical Services Ltd. - (Amalgamated) FAQs

The current trading price of Max Medical Services on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Max Medical Services stood at ₹0.00 Cr

The latest P/E ratio of Max Medical Services as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Max Medical Services as of 31-Dec-1969 is 0.00.

The 52-week high of Max Medical Services is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Max Medical Services is ₹44.21 ( Cr.) .

About Max Medical Services Ltd. - (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×